News
SBFMW
0.1403
-10.06%
-0.0157
Sunshine Biopharma Inc <SBFM.OQ> expected to post a loss of $8.00 a share - Earnings Preview
Sunshine Biopharma Inc SBFM.OQ expected to post a loss of $8.00 a share. The company is expected to report revenue of $7 million for the period ending March 31 2024. The one available analyst rating on the shares is "buy"
Reuters · 4d ago
SUNSHINE BIOPHARMA INC - AS A RESULT OF BORGERS' SETTLEMENT WITH SEC, COMPANY HAS DISMISSED BORGERS AS ITS INDEPENDENT ACCOUNTANT
Reuters · 5d ago
Weekly Report: what happened at SBFMW last week (0429-0503)?
Weekly Report · 5d ago
Weekly Report: what happened at SBFMW last week (0422-0426)?
Weekly Report · 04/29 12:53
SUNSHINE BIOPHARMA- EFFECTIVE APRIL 17, FILED CERTIFICATE OF AMENDMENT TO EFFECT 1-FOR-100 REVERSE SPLIT OF CO’S COMMON STOCK
Reuters · 04/23 21:01
Weekly Report: what happened at SBFMW last week (0415-0419)?
Weekly Report · 04/22 12:34
BUZZ-U.S. STOCKS ON THE MOVE-US chip stocks, Netflix, Tesla
The Dow and the S&P 500 edged higher on Friday. American Express rose after upbeat earnings. Netflix weighed on the Nasdaq following its dour forecast. Chip stocks, Netflix, Tesla are among the day's losers. The Dow Jones Industrial Average was up 0.45% in the morning.
Reuters · 04/19 15:12
BUZZ-U.S. STOCKS ON THE MOVE-Outset Medical, Interactive Brokers, US energy sector
Wall Street's main indexes fell in choppy trading on Wednesday. The Dow Jones Industrial Average was down 0.05% and the S&P 500 and the Nasdaq Composite were both down. United Airlines Holdings was among the top percentage gainers. Downbeat earnings reports from some industry majors added to the losses.
Reuters · 04/17 17:33
BUZZ-U.S. STOCKS ON THE MOVE-Children's Place, Travelers, First Horizon
Wall Street's main indexes rose on Wednesday. The Dow Jones Industrial Average .DJI was up 0.17% at 37,862.55. United Airlines Holdings was among the top percentage gainers. Children's Place, Travelers and First Horizon were among the biggest decliners.
Reuters · 04/17 14:50
BUZZ-U.S. STOCKS ON THE MOVE-Hasbro, Eli Lilly, Bloom Energy
Wall Street's main indexes eyed a higher open on Wednesday. Dow e-minis were up 0.19% in early trading. Top three NYSE percentage gainers premarket were VIA, United Airlines. Hasbro, Eli Lilly and Bloom Energy were up.
Reuters · 04/17 13:31
Weekly Report: what happened at SBFMW last week (0408-0412)?
Weekly Report · 04/15 12:24
Weekly Report: what happened at SBFMW last week (0401-0405)?
Weekly Report · 04/08 12:30
Weekly Report: what happened at SBFMW last week (0325-0329)?
Weekly Report · 04/01 12:26
Sunshine Biopharma Inc: Annual report
Press release · 03/28 23:35
Weekly Report: what happened at SBFMW last week (0318-0322)?
Weekly Report · 03/25 12:29
Weekly Report: what happened at SBFMW last week (0311-0315)?
Weekly Report · 03/18 12:28
Weekly Report: what happened at SBFMW last week (0304-0308)?
Weekly Report · 03/11 12:22
BUZZ-U.S. STOCKS ON THE MOVE-Apogee Therapeutics ,Target, Enviva
Wall Street's main indexes opened lower on Tuesday. The tech-heavy Nasdaq leading losses. Dow e-minis were down 0.40% at 38,867. The top three NYSE percentage gainers premarket were Apogee Therapeutics, Target and Enviva.
Reuters · 03/05 14:38
BUZZ-U.S. STOCKS ON THE MOVE-Super Micro Computer, Decker Outdoor, DoorDash
U.S. Stock index futures were muted on Monday after the S&P 500 and Nasdaq's record-closing highs in the prior session. Dow e-minis were down 0.26% at 39,041.25. Super Micro Computer, Decker Outdoor, DoorDash were among the day's top stocks.
Reuters · 03/04 12:34
Weekly Report: what happened at SBFMW last week (0226-0301)?
Weekly Report · 03/04 12:27
More
Webull provides a variety of real-time SBFMW stock news. You can receive the latest news about Sunshine Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About SBFMW
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a small chemotherapy molecule targeting pancreatic cancer. The K1.1 mRNA is developed for liver cancer. SBFM-PL4 is an anti-coronavirus compound. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio consisting of 50 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.